Abstract: Airway inflammation and imbalance between oxidant/anti-oxidant mechanisms are postulated to play a major role in the pathogenesis of COPD. The work aimed to evaluate serum uric acid among COPD patients and its correlation with the severity of the disease. Patients and methods: A retrospective cross-sectional study included 50 COPD patients, who attended Benha University Hospital from March 2022 to November 2023. All patients were subjected to the following; written consent from the patient, full history and clinical examination, ABG, CXR (P-A), pulmonary function tests, measuring serum creatinine and urea, measuring serum uric acid by enzymatic colorimetric assay in a fully automated analyzer. Results: There was a highly significant negative correlation between patients’ serum uric acid levels and FEV1.There was a highly significant negative correlation between patients’ serum uric acid levels and FEV1̸ FVC Conclusion: uric acid could be used as a chemical biomarker in predicting COPD severity and staging. Keywords: COPD, uric acid, severity
Hendy, R., & Mohammed, S. (2025). Evaluation of S.uric acid in COPD patients. Benha Medical Journal, 42(4), 608-615. doi: 10.21608/bmfj.2025.324288.2210
MLA
Rasha Mohamed Hendy; Salwa Hassan Mohammed. "Evaluation of S.uric acid in COPD patients", Benha Medical Journal, 42, 4, 2025, 608-615. doi: 10.21608/bmfj.2025.324288.2210
HARVARD
Hendy, R., Mohammed, S. (2025). 'Evaluation of S.uric acid in COPD patients', Benha Medical Journal, 42(4), pp. 608-615. doi: 10.21608/bmfj.2025.324288.2210
VANCOUVER
Hendy, R., Mohammed, S. Evaluation of S.uric acid in COPD patients. Benha Medical Journal, 2025; 42(4): 608-615. doi: 10.21608/bmfj.2025.324288.2210